Literature DB >> 24832747

Loss of TLR4 does not prevent influenza A-induced mortality.

Luisa Morales-Nebreda1, Gökhan M Mutlu, G R Scott Budinger, Kathryn A Radigan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24832747      PMCID： PMC4225852          DOI： 10.1164/rccm.201401-0193LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  11 in total

1.  Limits of a deletion spanning Tlr4 in C57BL/10ScCr mice.

Authors:  A Poltorak; I Smirnova; R Clisch; B Beutler
Journal:  J Endotoxin Res       Date:  2000

2.  Non-canonical inflammasome activation targets caspase-11.

Authors:  Nobuhiko Kayagaki; Søren Warming; Mohamed Lamkanfi; Lieselotte Vande Walle; Salina Louie; Jennifer Dong; Kim Newton; Yan Qu; Jinfeng Liu; Sherry Heldens; Juan Zhang; Wyne P Lee; Merone Roose-Girma; Vishva M Dixit
Journal:  Nature       Date:  2011-10-16       Impact factor: 49.962

3.  Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice.

Authors:  Yumi Hashimoto; Takeshi Moki; Takenori Takizawa; Akiko Shiratsuchi; Yoshinobu Nakanishi
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

4.  FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.

Authors:  Mohamed F Abdul-Careem; M Firoz Mian; Amy E Gillgrass; Meghan J Chenoweth; Nicole G Barra; Tiffany Chan; Amal A Al-Garawi; Marianne V Chew; Geoffry Yue; Nico van Roojen; Zhou Xing; Ali A Ashkar
Journal:  Antiviral Res       Date:  2011-09-14       Impact factor: 5.970

5.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.

Authors:  K Hoshino; O Takeuchi; T Kawai; H Sanjo; T Ogawa; Y Takeda; K Takeda; S Akira
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

6.  Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo.

Authors:  Q M Nhu; K Shirey; J R Teijaro; D L Farber; S Netzel-Arnett; T M Antalis; A Fasano; S N Vogel
Journal:  Mucosal Immunol       Date:  2009-10-28       Impact factor: 7.313

7.  Characterization of a congenitally LPS-resistant, athymic mouse strain.

Authors:  S N Vogel; C T Hansen; D L Rosenstreich
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

8.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

9.  The TLR4 antagonist Eritoran protects mice from lethal influenza infection.

Authors:  Kari Ann Shirey; Wendy Lai; Alison J Scott; Michael Lipsky; Pragnesh Mistry; Lioubov M Pletneva; Christopher L Karp; Jaclyn McAlees; Theresa L Gioannini; Jerrold Weiss; Wilbur H Chen; Robert K Ernst; Daniel P Rossignol; Fabian Gusovsky; Jorge C G Blanco; Stefanie N Vogel
Journal:  Nature       Date:  2013-05-01       Impact factor: 49.962

10.  Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.

Authors:  Yumiko Imai; Keiji Kuba; G Greg Neely; Rubina Yaghubian-Malhami; Thomas Perkmann; Geert van Loo; Maria Ermolaeva; Ruud Veldhuizen; Y H Connie Leung; Hongliang Wang; Haolin Liu; Yang Sun; Manolis Pasparakis; Manfred Kopf; Christin Mech; Sina Bavari; J S Malik Peiris; Arthur S Slutsky; Shizuo Akira; Malin Hultqvist; Rikard Holmdahl; John Nicholls; Chengyu Jiang; Christoph J Binder; Josef M Penninger
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582
View more
  6 in total

Review 1.  Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense.

Authors:  M M Leiva-Juárez; J K Kolls; S E Evans
Journal:  Mucosal Immunol       Date:  2017-08-16       Impact factor: 7.313

2.  Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.

Authors:  Allison L Totura; Alan Whitmore; Sudhakar Agnihothram; Alexandra Schäfer; Michael G Katze; Mark T Heise; Ralph S Baric
Journal:  mBio       Date:  2015-05-26       Impact factor: 7.867

Review 3.  Oxidized Phospholipids in Healthy and Diseased Lung Endothelium.

Authors:  Pratap Karki; Konstantin G Birukov
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

Review 4.  Toll-like receptor 4 in acute viral infection: Too much of a good thing.

Authors:  Judith Olejnik; Adam J Hume; Elke Mühlberger
Journal:  PLoS Pathog       Date:  2018-12-20       Impact factor: 6.823

5.  Toll-like receptor 4 mediates blood-brain barrier permeability and disease in C3H mice during Venezuelan equine encephalitis virus infection.

Authors:  Bradley S Hollidge; Courtney A Cohen; Justice Akuoku Frimpong; Catherine V Badger; John M Dye; Connie S Schmaljohn
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 6.  Targeting TLR4 Signaling to Blunt Viral-Mediated Acute Lung Injury.

Authors:  Kari Ann Shirey; Jorge C G Blanco; Stefanie N Vogel
Journal:  Front Immunol       Date:  2021-07-02       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.